共 50 条
- [41] Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis JOURNAL OF CROHNS & COLITIS, 2022, 16 : I424 - I424
- [44] Ustekinumab in refractory Ulcerative Colitis: single-center, real-world experience JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1709 - I1709
- [47] Long-term real-world data of Ustekinumab in Ulcerative Colitis - the Stockholm Ustekinumab study - STOCUSTE JOURNAL OF CROHNS & COLITIS, 2023, 17 : 747 - 747
- [49] Real-world use and effectiveness of golimumab for ulcerative colitis in Canada JOURNAL OF CROHNS & COLITIS, 2016, 10 : S396 - S396
- [50] Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis JOURNAL OF CROHNS & COLITIS, 2022, 16 (10): : 1562 - 1570